tiprankstipranks
TipRanksTop Financial ExpertsInsidersJames Barrett

James Barrett Insider Profile

11 Followers
James Barrett, Director at Senseonics Holdings, holds 664.80K shares in Senseonics Holdings (Ticker: SENS), holds 82.98M shares in Adaptimmune Therapeutics (Ticker: ADAPY), holds 2.48M shares in Liquidia Technologies (Ticker: LQDA).
See the Hottest Stocks Based on Insider Trading >
tipranks
James Barrett

James Barrett
Senseonics Holdings (SENS)
Director

Ranked #8,443 out of 108,699 Corporate Insiders

Profitable Transactions

32%
18 out of 56 Profitable Transactions

Average Return

+9.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$439M
40.38%
37.30%
8.00%
6.91%
7.41% Others
A breakdown of James Barrett's holdings
See the Top Stocks by Insiders

Insider Roles

Liquidia Technologies
(LQDA)
Ten Percent Owner
Crescent Biopharma
(CBIO)
Director, Ten Percent Owner
Ardelyx
(ARDX)
Ten Percent Owner
Gyre Therapeutics
(GYRE)
Ten Percent Owner
+8 other positions
Roles that James Barrett holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Crescent Biopharma
(CBIO)
Rating:Informative Buy
Date:Jan 09, 2014 - Jan 09, 2015
Return:+800.00%
The most profitable trade made by James Barrett
See the Latest Stocks Traded by Insiders

James Barrett's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SENS
Senseonics Holdings
Jan 04, 2019
Director
Uninformative Buy
9.75K
$6.21M
KANT
Kineta
Dec 19, 2017
―
Informative Buy
10.00M
$1.87M
APPN
Appian
Feb 15, 2018
Ten Percent Owner
Uninformative Buy
―
$78.05K
SYBX
Synlogic
Jan 26, 2018
Ten Percent Owner
Uninformative Buy
4.00M
$5.16M
SURF
Surface Oncology
Apr 23, 2018
―
Uninformative Buy
―
$3.54M
MULE
Mulesoft Inc
May 09, 2018
―
Uninformative Sell
―
$0.00
LQDA
Liquidia Technologies
Aug 01, 2018
Ten Percent Owner
Uninformative Buy
―
$177.32M
ADAPY
Adaptimmune Therapeutics
Sep 10, 2018
Ten Percent Owner
Informative Buy
4.98M
$2.16M
TSRO
Tesaro
Mar 06, 2018
―
Informative Buy
6.68M
$725.74M
ARDX
Ardelyx
May 30, 2018
Ten Percent Owner
Uninformative Buy
1.67M
$35.12M
SUPN
Supernus Pharmaceuticals
Mar 24, 2016
Director
Uninformative Sell
―
$10.35M
CBIO
Crescent Biopharma
May 11, 2018
Director, Ten Percent Owner
Uninformative Sell
169.89K
$163.78M
LOXO
Loxo Oncology
Aug 06, 2014
―
Uninformative Buy
―
$419.91M
TCON
TRACON Pharmaceuticals
Mar 27, 2018
―
Informative Buy
1.91M
$110.91K
ZSANQ
Zosano Pharma
Feb 14, 2017
―
Informative Sell
2.21M
$43.17K
DATA
Tableau
Dec 04, 2014
―
Uninformative Buy
―
$15.27M
ROKA
Sorrento Tech Inc
Jul 22, 2014
―
Uninformative Buy
―
$2.09M
BOX
Box
Jan 22, 2015
Ten Percent Owner
Informative Buy
―
$5.44M
CLVSQ
Clovis Oncology
Mar 01, 2017
―
Uninformative Buy
―
$8.61
VTAE
Vitae Pharma
Jul 02, 2015
―
Uninformative Buy
―
$33.56K
HPTX
Hyperion Therapeutics
May 11, 2015
―
Uninformative Sell
109.67M
―
~DERM
Dermira
Oct 08, 2014
―
Uninformative Buy
―
$65.68M
FOLD
Amicus
Mar 09, 2012
―
Informative Buy
5.27M
$66.43M
~HIVE
Aerohive Networks
Apr 03, 2014
―
Uninformative Buy
―
$20.75M
GYRE
Gyre Therapeutics
Dec 05, 2013
Ten Percent Owner
Informative Sell
80.70K
$30.35M
CRCM
Care
Nov 08, 2017
―
Uninformative Buy
―
$33.85M
MM
Millennial Media
Oct 30, 2012
―
Informative Sell
21.47M
$14.34M
EPZM
Epizyme
Jan 12, 2016
―
Informative Buy
10.00M
$9.20M
VIRX
Viracta Therapeutics
Aug 29, 2014
―
Informative Sell
2.13M
$46.59K
WDAY
Workday
Apr 11, 2013
Ten Percent Owner
Uninformative Buy
―
$2.23M
GRPN
Groupon
Sep 17, 2013
Ten Percent Owner
Uninformative Buy
―
$899.21K
~VG
Vonage Holdings
Mar 15, 2011
―
Uninformative Buy
―
$478.43K
XOOM
Xoom Corp
Oct 31, 2013
―
Uninformative Buy
―
―
INWK
InnerWorkings
Mar 30, 2012
―
Uninformative Buy
―
$44.85K
ARDMQ
Aradigm
―
―
―
$133.63
ADNC
Audience Inc
Nov 06, 2013
―
Uninformative Buy
―
―
WIFI
Boingo Wireless
Dec 12, 2013
―
Uninformative Buy
―
$0.00
~~ECHO
Echo Global Logistics
Mar 01, 2012
―
Uninformative Buy
―
$0.00
FIO
Fusion-IO
Jun 07, 2011
―
Informative Buy
―
―
PRTK
Paratek Pharmaceuticals
Feb 03, 2009
―
Uninformative Buy
―
$4.65M
OMTH
Omthera
―
―
―
―
ECOM
ChannelAdvisor
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see James Barrett's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

James Barrett insider profile FAQ

What is the percentage of profitable transactions made by James Barrett?
The percentage of profitable transactions made by James Barrett is 32%.
    What is the average return per transaction made by James Barrett?
    The average return per transaction made by James Barrett is 9.30%.
      What stocks does James Barrett hold?
      James Barrett holds: SENS, KANT, APPN, SYBX, SURF, MULE, LQDA, ADAPY, TSRO, ARDX, SUPN, CBIO, LOXO, TCON, ZSANQ, DATA, ROKA, BOX, CLVSQ, VTAE, HPTX, ~DERM, FOLD, ~HIVE, GYRE, CRCM, MM, EPZM, VIRX, WDAY, GRPN, ~VG, XOOM, INWK, ARDMQ, ADNC, WIFI, ~~ECHO, FIO, PRTK, OMTH, ECOM stocks.
        What was James Barrett’s latest transaction?
        James Barrett latest transaction was an Uninformative Buy of $9.75K.
          What was James Barrett's most profitable transaction?
          James Barrett’s most profitable transaction was an Informative Buy of CBIO stock on January 9, 2014. The return on the trade was 800.00%.
            What is James Barrett's role in Senseonics Holdings?
            James Barrett's role in Senseonics Holdings is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.